Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes

Gut

Volumn 52, Issue 12, 2003, Pages 1774-1778

  Granato, A ^a   Gores, G ^b   Vilei, M T ^a   Tolando, R ^c   Ferraresso, C ^a   Muraca, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILIRUBIN; BILIRUBIN GLUCURONIDE; GLYCOCHENODEOXYCHOLIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CHOLESTASIS; CONTROLLED STUDY; HYPERBILIRUBINEMIA; IN VITRO STUDY; LIVER CELL; LIVER CELL DAMAGE; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; BILIRUBIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYMES; HEPATOCYTES; RATS; REACTIVE OXYGEN SPECIES;

EID: 0344868501     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.12.1774     Document Type: Article

References (30)

1. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, et al. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 1995;109:1249-56.
2. Galle PR, Theilmann L, Raedsch R, et al. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepotology 1990;12:486-91.
3. Guicciardi ME, Gores GJ. Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 2002;34:387-92.
4. Yerushalmi B, Dahl R, Devereaux MW, et al. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001;33:616-26.
5. Sokol RJ, Straka MS, Dahl R, et al. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr Res 2001;49:519-31.
6. Rodrigues CM, Fan G, Wong PY, et al. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998;4:165-78.
7. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995;21:1725-41.
8. Kurosawa H, Que FG, Roberts LR, et al. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 1997;72:G1587-93.
9. Miyoshi H, Rust C, Guicciardi ME, et al. NF-kappaB is activated in cholestasis and functions to reduce liver injury. Am J Pathol 2001;158:967-75.
10. Patel T, Gores GJ. Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E. Toxicol Appl Pharmacol 1997;142:116-22.
11. Muraca M, Fevery J, Blanckaert N. Analytic aspects and clinical interpretation of serum bilirubins. Semin Liver Dis 1988;8:137-47.
12. Ostrow JD, Pascolo L, Tiribelli C. Mechanisms of bilirubin neurotoxicity. Hepatology 2002;35:1277-80.
13. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-6.
14. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987;84:5918-22.
15. Tomaro ML, Batlle AM. Bilirubin: its role in cytoprotection against oxidative stress. Int J Biochem Cell Biol 2002;34:216-20.
16. Van Hootegem P, Fevery J, Blanckaert N. Serum bilirubins in hepatobiliary disease: comparison with other liver function tests and changes in the postobstructive period. Hepatology 1985;5:112-17.
17. Ostrow JD, Hammaker L, Schmid R. The preparation of crystalline bilirubin-C14. J Clin Invest 1961;40:1442-52.
18. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;113:29-83.
19. Vilei MT, Granato A, Ferraresso C, et al. Comparison of pig, human and rat hepatocytes as a source of liver specific metabolic functions in culture systems - implications for use in bioartificial liver devices. Int J Artif Organs 2001;24:392-6.
20. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994;94:2183-92.
21. Zeid IM, Bronk SF, Fesmier PJ, et al. Cytoprotection by fructose and other ketohesoses during bile salt-induced apoptosis of hepatocytes. Hepatology 1997;25:81-6.
22. Sokol RJ, McKim JM Jr, Goff MC, et al. Vitamin E reduces oxidant injury to mitochondria and hepatotoxicity of intravenous taurochenodeoxycholic acid in the rat. Gastroenterology 1998;114:164-74.
23. Meyer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-7.
24. Hammerman C, Goldschmidt D, Caplan MS, et al. Protective effect of bilirubin in ischemia-reperfusion injury in the rat intestine. J Pediatr Gastroenterol Nutr 2002;35:344-9.
25. Neale G, Lewis B, Weaver V. Serum bile acids in liver disease. Gut 1971;12:145-52.
26. Silva RF, Rodrigues CM, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 2001;34:402-8.
27. Rodriguez CM, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998;101:2790-9.
28. Takenaka Y. Bilirubin adsorbent column for plasma perfusion. Ther Apher 1998;2:129-33.
29. Pazzi P, Scagliarini R, Puviani AC, et al. Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice. Int J Artif Organs 2000;23:312-18.
30. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58.